Aspen Neuroscience

Kim Raineri, Chief Technology Officer

Oct. 10 | 11:30am | Rentschler ATMP Ballroom 

San Diego, CA


Aspen Neuroscience is a development stage, private biotechnology company focused on personalized cell therapies. We are developing autologous (the patient’s own) induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical need, beginning with autologous neuron replacement for Parkinson’s disease (PD). As a leading iPSC platform company, we combine stem cell biology with the latest artificial intelligence and genomic approaches to investigate patient-specific, restorative treatments. We have developed a best-in-class platform to create and characterize pluripotent-derived cell medicines, including in-house bioinformatics, manufacturing and QC. 


By using this website you agree to accept our Privacy Policy and Terms & Conditions